Related content

Targeted Gene Therapy of Ovarian Cancer Using an Ovarian-Specific Promoter

By Bao R.   Selvakumaran M.   Hamilton T.C.  

Gynecologic Oncology, Vol. 84, Iss. 2, 2002-02 ,pp. : 228-234

Elsevier

Access to resources Recommend Favorite

Mammary gland tumor formation in transgenic mice overexpressing stromelysin-1

By Sympson C.J.   Bissell M.J.   Werb Z.  

Seminars in Cancer Biology, Vol. 6, Iss. 3, 1995-06 ,pp. : 159-163

Academic Press

Access to resources Recommend Favorite

Heme Oxygenase-1 Gene Promoter Polymorphism is Associated with Risk of Gastric Adenocarcinoma and Lymphovascular Tumor Invasion

By Lo Su-Shun   Lin Shu-Chun   Wu Chew-Wun   Chen Jen-Hao   Yeh Wen-I   Chung Ming-Yi   Lui Win-Yiu  

Annals of Surgical Oncology, Vol. 14, Iss. 8, 2007-08 ,pp. : 2250-2256

Springer Publishing Company

Access to resources Recommend Favorite

Cell-specific expression of the analgesic-antitumor peptide coding sequence under the control of the human α-fetoprotein gene promoter and enhancer

By  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 3, 2015-01 ,pp. : 863-867

Spandidos Publications

Access to resources Recommend Favorite

Generation of human tumor-specific CTLs in HLA-A2.1–transgenic mice using unfractionated peptides from eluates of human primary breast and ovarian tumors

By Gritzapis Angelos   Sotiriadou Nectaria   Papamichail Michael   Baxevanis Constantin  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 11, 2004-11 ,pp. : 1027-1040

Springer Publishing Company

Access to resources Recommend Favorite